Summary: Halo Healthcare Inc. is a 2012 restructured and recapitalized Southern California growth company, founded as NeoMatrix LLC. The Company’s mission is to provide women with early, affordable, noninvasive, breast cancer risk assessment and detection tests. Early detection saves lives and reduces healthcare costs. An annual FDA cleared HALO® Breast Test provides women and physicians scaled risk data for developing breast cancer, thus enabling proactive personalized breast cancer prevention measures. The HALO Breast Test provides valuable data for women who may be at risk for developing breast cancer including women with a family history, women with dense breasts and women on hormones. HaloHC will operate clinical laboratories for increased revenues, improved affordability and accelerated adoption. The Company has a technology platform focused on protein based biomolecular diagnostic products for sustainable growth. The AURA Breast Test is in clinical development and will revolutionize the diagnosis of breast cancer using proprietary biomarkers licensed by our Company.